AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CLARITY PHARMACEUTICALS LTD

1.800

-0.120-6.25%

Volume:5.17M

Turnover:9.38M

Market Cap:669.65M

PE:-6.18

High:1.940

Open:1.940

Low:1.785

Close:1.920

52wk High:5.320

52wk Low:1.785

Shares:372.03M

Float Shares:274.26M

Volume Ratio:2.05

T/O Rate:1.88%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.291

EPS(LYR):-0.291

ROE:-77.54%

ROA:-45.12%

PB:3.60

PE(LYR):-6.18

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Clarity Pharmaceuticals Hits Recruitment Target for Main Group of Cancer Treatment Trial's Cohort Expansion

MT Newswires Live

ASX Penny Stocks To Watch In October 2026

Simply Wall St.

Clarity Pharmaceuticals Fiscal 2026 Loss Widens, Revenue Up

MT Newswires Live

Clarity Pharmaceuticals - FY Loss Attributable A$107.2 Mln

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://nz.tigermarketb.com/stock/CU6.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"CU6.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CU6.AU\",,,,,undefined,":{"symbol":"CU6.AU","market":"AU","secType":"STK","nameCN":"CLARITY PHARMACEUTICALS LTD","latestPrice":1.8,"timestamp":1791868320000,"preClose":1.92,"halted":0,"volume":5169507,"delay":0,"changeRate":-0.062499999999999944,"nameEN":"CLARITY PHARMACEUTICALS LTD","floatShares":274264090,"shares":372030071,"eps":-0.291397,"marketStatus":"Not Yet Opened","change":-0.12,"latestTime":"10-13 16:12:00 AEDT","open":1.94,"high":1.94,"low":1.785,"amount":9376981,"amplitude":0.080729,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.291397,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791932400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":1.92,"openAndCloseTimeList":[[1791846000000,1791867600000]],"volumeRatio":2.045721931966446,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CU6.AU","preClose":1.8,"auctionPrice":1.8,"auctionVolume":271,"auctionTime":1791921654782,"referenceTime":1791887404086,"auction":1,"marketStatus":"盘前竞价","timestamp":1791921654782}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CU6.AU\",,,,,undefined,":{"symbol":"CU6.AU","floatShares":274264090,"roa":"-45.12%","roe":"-77.54%","lyrEps":-0.291397,"volumeRatio":2.045721931966446,"shares":372030071,"dividePrice":0,"high":1.94,"amplitude":0.080729,"preClose":1.92,"low":1.785,"week52Low":1.785,"pbRate":"3.60","psRate":"63.62","week52High":5.32,"institutionHeld":0,"latestPrice":1.8,"eps":-0.291397,"divideRate":0,"volume":5169507,"delay":0,"ttmEps":-0.291397,"open":1.94,"prevYearClose":3.38,"prevWeekClose":1.845,"prevMonthClose":2.1,"prevQuarterClose":2.1,"fiveDayClose":2.02,"twentyDayClose":2.19,"sixtyDayClose":2.23,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CU6.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CU6.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CU6.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673244046","title":"Clarity Pharmaceuticals Hits Recruitment Target for Main Group of Cancer Treatment Trial's Cohort Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2673244046","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673244046?lang=en_us&edition=fundamental","pubTime":"2026-10-08 08:17","pubTimestamp":1791418676,"startTime":"0","endTime":"0","summary":"Clarity Pharmaceuticals (ASX:CU6) achieved its recruitment target for the main group of the cohort expansion in a phase 1/2a trial that is evaluating a potential prostate cancer treatment, according t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","CU6.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081514","title":"ASX Penny Stocks To Watch In October 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081514","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081514?lang=en_us&edition=fundamental","pubTime":"2026-10-06 03:02","pubTimestamp":1791226943,"startTime":"0","endTime":"0","summary":"As the Australian market prepares for a potentially positive start to the week, investor sentiment remains cautious due to fluctuating bond yields and geopolitical factors. In this climate, penny stocks—often representing smaller or newer companies—continue to offer unique growth opportunities despite being considered a niche investment area. When these stocks are supported by solid financial health, they can provide attractive prospects for investors seeking under-the-radar companies with...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cu6/clarity-pharmaceuticals-shares/news/asx-penny-stocks-to-watch-in-october-2026-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cu6/clarity-pharmaceuticals-shares/news/asx-penny-stocks-to-watch-in-october-2026-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CU6.AU","BK7058","CLX.AU","BK7096","BK7121","QAL.AU","BK7062"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662225507","title":"Clarity Pharmaceuticals Fiscal 2026 Loss Widens, Revenue Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2662225507","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662225507?lang=en_us&edition=fundamental","pubTime":"2026-08-27 11:14","pubTimestamp":1787800481,"startTime":"0","endTime":"0","summary":"Clarity Pharmaceuticals (ASX:CU6) logged a AU$0.291 loss per share for fiscal 2026, compared with a loss of AU$0.201 a year ago, a Thursday filing showed.For the 12 months ended June 30, revenue from ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","CU6.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662724657","title":"Clarity Pharmaceuticals - FY Loss Attributable A$107.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662724657","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662724657?lang=en_us&edition=fundamental","pubTime":"2026-08-27 10:32","pubTimestamp":1787797973,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUE8FSRM4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CU6.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":28,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CU6.AU\",params:#limit:6,delay:true,,,undefined,":[]}}